Article Text

Download PDFPDF

Analysis of LMP and TAP polymorphisms by polymerase chain reaction-restriction fragment length polymorphism in rheumatoid arthritis
  1. J Vinascoa,
  2. A Frailea,
  3. A Nietoa,
  4. Y Berauna,
  5. E Parejab,
  6. L Mataranc,
  7. J Martína
  1. aInstituto de Parasitología y Biomedicina “López Neyra”, CSIC, Granada, Spain, bSección de Biología Teórica, Hospital Virgen de las Nieves, Granada, Spain, cServicio de Reumatología, Hospital Virgen de las Nieves, Granada, Spain
  1. Dr J Martín, Instituto de Parasitología y Biomedicina “Lopez-Neyra”, C/ Ventanilla nº 11 18001 Granada, Spain.


OBJECTIVE The aim of this study was to investigate the relation between the polymorphism of large molecular weight proteasome (LMP) (LMP2-LMP7) and transporter associated with antigen processing (TAP) (TAP1-TAP2) genes and rheumatoid arthritis (RA).

METHODS Sixty RA patients and 102 ethnically matched unrelated healthy subjects were typed for LMP, TAP, and disease associated HLA-DRB1 alleles by using a new strategy based on polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) with amplification created restriction sites.

RESULTS The polymorphism of LMP (LMP2-LMP7) and TAP (TAP1-TAP2) genes was examined in shared epitope positive and negative RA patients and controls. No significant differences in the LMP or TAP allele frequencies were observed between the total patient and control groups or the patients and controls positive or negative for the shared epitope.

CONCLUSION The data suggest that the polymorphisms of LMP and TAP genes do not have an important influence in the pathogenesis of RA, although larger studies will be needed to provide more conclusive evidence on the role of these genes in RA. A new, highly reliable strategy for typing LMP alleles is also described.

  • large molecular weight proteasome
  • transporter assoicated with antigen processing
  • rheumatoid arthritis
View Full Text

Statistics from


    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.